Coats disease

Authors

Keywords:

COATS DISEASE, TELANGIECTASIAS, DIAGNOSIS

Abstract

Introduction: Coats disease is a rare, idiopathic retinal vasculopathy that can progress to exudative retinal detachment and neovascular glaucoma. Typically occurring in childhood, it is the third most common cause of childhood leukocoria.

Case report: Patient masculine of two years of age, coming from rural area. You attended consultation, because he/she suckles her he/she noticed that the boy deviates the right eye toward it was since he was born.

Conclusions: Coats disease simulates other retinal vasculopathies and retinoblastoma. The behavior to be followed will depend on the clinical form of presentation and associated complications.

Downloads

Download data is not yet available.

Author Biographies

Sandra María Jalilo Hernández, Hospital Pediátrico Docente Pepe Portilla. Pinar del Rio .Cuba

Especialista de primer grado en Medicina General Integral y Oftalmología. Profesor Asistente. Máster en Urgencia Medicas en APS .

Ramon Santander Acosta, Hospital Docente Clínico Quirúrgico Abel Santamaría Cuadrado. Pinar del Rio .Cuba

Especialista de primer grado en Oftalmología. Profesor Instructor.

Nayaris Gomez Martinez, Hospital Docente Clínico Quirúrgico Abel Santamaría Cuadrado. Pinar del Rio .Cuba

Especialista de segundo grado en Oftalmología. Profesor Auxiliar. Máster en Longevidad Satisfactoria .

References

1. Fernandes H, Umashankar T, Richie AJ, Hegde S. Coats - enfermedad de los ojos rara vez encontrada por patólogos. Indian J Pathol Microbiol [Internet] 2018 [citado el 18/05/2019]; 61(1): [aprox. 2p.]. Disponible en: http://www.ijpmonline.org/text.asp?2018/61/1/98/228199

2. Andonegui J, Aranguren M, Berástegui L. Coats disease of adult onset. Arch Soc Esp Oftalmol [Internet]. 2008 Feb [citado 01/07/2019]; 83(2): [aprox. 3p.]. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0365-66912008000200010&lng=es

3. lvarez-Rivera LG, Abraham-Marín ML, Flores-Orta HJ, Mayorquín-Ruiz M, Cortés-Luna CF. Coat's disease treated with bevacizumab (Avastin®). Arch Soc Esp Oftalmol [Internet]. 2008 Mayo [citado 01/07/2019]; 83(5): [aprox. 2p.]. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0365-66912008000500010

4. Sein J, Tzu J, Murray T, Berrocal A. Treatment of Coats' Disease With Combination Therapy of Intravitreal Bevacizumab, Laser Photocoagulation, and Sub-Tenon Corticosteroids. Ophthalmic Surg Lasers Imaging Retina [Internet] 2016 [citado el 18/05/2019]; 47(5): [aprox. 6p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/27183548

5. Ryan SJ, Retina MR. Enfermedades vasculares retinianas. Sección II: Enfermedad de Coats. Madrid: Editorial Marbán Libros; 2013. p. 1058-1069.

6. Sigler EJ, Randolph JC, Calzada JI, Wilson MW, Haik BG. Current management of Coats’ disease. Surv Ophthalmol [Internet]. 2014 [citado el 18/05/2019]; 59(1): [aprox. 16p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/24138893

7. Villegas VM, Gold AS, Berrocal AM, Murray TG. Advanced Coats’ disease treated with intravitreal bevacizumab combined with laser vascular ablation. Clin Ophthalmol [Internet] 2014 [citado el 18/05/2019]; 8: [aprox. 3p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4037307/

8. Suesskind D, Altpeter E, Schrader M, Bartz-Schmidt KU, Aisenbrey S. Pars plana vitrectomy for treatment of advanced Coats’ disease-presentation of a modified surgical technique and long-term follow-up. Graefes Arch Clin Exp Ophthalmol [Internet] 2014 [citado el 18/05/2019]; 252(6): [aprox. 6p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/24218042

9. Bhat V, D’Souza P, Shah PK, Narendran V. Risk of tractional retinal detachment following intravitreal bevacizumab along with subretinal fluid drainage and cryotherapy for stage 3B Coats’ disease. Middle East Afr J Ophthalmol [Internet] 2016 [citado el 18/05/2019]; 23(2): [aprox. 3p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/27162454

10. Stanga PE, Jaberansari H, Bindra MS, Gil-Martinez M, Biswas S. Transscleral drainage of subretinal fluid, anti-vascular endothelial growth factor, and wide fieldimaging-guided laser in Coats exudative retinal detachment. Retina [Internet] 2016 [citado el 18/05/2019]; 36(1): [aprox. 6p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/26355946

11. Karacorlu M, Hocaoglu M, Sayman M, Arf S. Long-term anatomical and functional outcomes following vitrectomy for advanced Coats disease. Retina [Internet] 2017 [citado el 18/05/2019]; 37(9): [aprox. 7p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/27984550

12. Abujamra S. Telangiectasias perimaculares idiopáticas. Rev.bras.oftalmol [Internet]. 2012 Aug [cited 21/03/2019]; 71(4): [aprox. 3p.]. Disponible en: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0034-72802012000400001&lng=en

13. Peng J, Zhang Q, Jin H, Fei P, Zhao P. A modified technique for the transconjunctival and sutureless external drainage of subretinal fluid in bullous exudative retinal detachment using a 24-G i.v. catheter. Ophthalmologica [Internet]. 2017 [citado el 18/05/2019]; 238(4): [aprox. 6p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/28866667

14. Grosso A, Pellegrini M, Cereda MG, Panico C, Staurenghi G, Sigler EJ. Pearls and pitfalls in diagnosis and management of Coats disease. Retina [Internet]. 2015 [citado el 18/05/2019]; 35(4): [aprox. 9p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/25811949

Downloads

Published

2020-03-06

How to Cite

1.
Jalilo Hernández SM, Santander Acosta R, Gomez Martinez N. Coats disease. Rev Ciencias Médicas [Internet]. 2020 Mar. 6 [cited 2025 Oct. 19];24(2):e4199. Available from: https://revcmpinar.sld.cu/index.php/publicaciones/article/view/4199

Issue

Vol. 24 No. 2 (2020)

Section

CASE REPORTS

License

Authors who have publications with this journal agree to the following terms: Authors will retain their copyrights and grant the journal the right of first publication of their work, which will be publication of their work, which will be simultaneously subject to the Creative Commons Attribution License (CC-BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.

Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g.: deposit it in an institutional telematic archive or publish it in a volume). Likewise, and according to the recommendations of the Medical Sciences Editorial (ECIMED), authors must declare in each article their contribution according to the CRediT taxonomy (contributor roles). This taxonomy includes 14 roles, which can be used to represent the tasks typically performed by contributors in scientific academic production. It should be consulted in monograph) whenever initial publication in this journal is indicated. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which may produce interesting exchanges and increase citations of the published work. (See The effect of open access). https://casrai.org/credit/